#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Insulinoma Follicle centre lymphoma follicular grade I II – III refractory Malignant oligodendroglioma Netherton's syndrome Thymic carcinoma Osteosarcoma Phaeochromocytoma HER2 gene amplification Leukodystrophy Small cell lung cancer recurrent Solitary fibrous tumour Cervix carcinoma Extraskeletal ossification Fusarium infection Ocular myasthenia More trials…

    Learn about Rare Diseases

    Progressive supranuclear palsy – Life with Disease Lymphangioma – Trials in Disease Pulmonary sarcoidosis – Trials in Disease Hereditary angioedema – Basic Information Hairy cell leukaemia – Diagnostics MELAS syndrome – Diagnostics SAPHO syndrome – Basic Information CADASIL Paroxysmal nocturnal haemoglobinuria Congenital nephrogenic diabetes insipidus – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Citric Acid Monohydrate Amiodarone Hydrochloride Neob Loperamide Amlitelimab Vanglusagene Ensiparvovec Bemnifosbuvir Hemisulfate Cetrorelix Zinc Sulphate Heptahydrate Propofol Interferon Beta-1B Simoctocog Alfa Obeticholic Acid Mexiletine SKB410 Seralutinib Alectinib Isoleucine Betamethasone Dipropionate Abt-494 More therapies…

    Learn about Your Condition

    Pre-eclampsia Facial paresis Vascular calcification Hepatic fibrosis Uterine cancer Biliary tract disorder Liver transplant rejection Cervix carcinoma stage III Gastric cancer Colon cancer stage III Extra-osseous Ewing's sarcoma Sexual dysfunction Vomiting Anogenital warts Hairy cell leukaemia recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effectiveness of Apixaban and Enoxaparin Sodium in Preventing Blood Clots in Patients with Autoimmune Hemolytic Anemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Autoimmune haemolytic anaemia
    Investigated Drugs:
    • Enoxaparin Sodium
    • Apixaban
    France

  • Study on Amikacin for Treating Mycobacterium Xenopi Lung Infection in Patients Using Amikacin and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amikacin
    • Ethambutol Hydrochloride
    • Amoxicillin
    France

  • Study of venetoclax, obinutuzumab and zanubrutinib combination therapy in young patients with high-risk Chronic Lymphocytic Leukemia and residual disease

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Chlorphenamine Maleate
    • Lamivudine
    • Allopurinol
    Italy

  • Study of Ponatinib and Chemotherapy for Adults with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Lenograstim
    • Filgrastim
    • Idarubicin Hydrochloride
    Italy

  • Study on Botulinum Toxin Type A Injection for Patients with Inability to Belch Due to Retrograde Cricopharyngeus Dysfunction

    Recruiting

    3 1 1
    Investigated Diseases:
    • Eructation
    • Oesophageal disorder
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Sodium Chloride
    Belgium

  • Study on Pembrolizumab and Olaparib for Patients with Extensive-Stage Small-Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Olaparib
    • Carboplatin
    • Cisplatin
    Italy
Previous Page
1 … 528 529 530 531 532 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!